Hold the Presses is your online newsportal en brings press releases from around the world. Journalists can use it for free, although it is their responsibilty to check the news. Hold the Presses is in no way responsible for the content of the press releases, the Sender is.
We hope you enjoy reading the news we bring you on this website. If a message is published that is not acceptable, we apologize. Please contact us and we will remove the message as soon as possible.

WASHINGTON, BUENOS AIRES, Argentina, MADRID and GENEVA, August 31, 2017 /PRNewswire/ -- On August 29th, the U.S. Food and Drug Administration (FDA) approved Chemo Research's New Drug Application (NDA) for benznidazole. This is the first drug ever approved by the FDA to treat Chagas...

DUBLIN, August 31, 2017 /PRNewswire/ -- The "Patient Lateral Transfer Market - Global Forecast to 2022" report has been added to Research and Markets' offering. The global patient lateral transfer market is projected to reach USD 305.4 Million by 2022 from USD 196.4 Million in...